Molecular screening of Chinese medicinal plants for progestogenic and anti-progestogenic activity

Journal of Biosciences

Volumn 39, Issue 3, 2014, Pages 453-461

  Ahmed, Hm Manir ^a   Yeh, Jan Ying ^b   Tang, Yi Chia ^a   Cheng, Winston Teng Kuei ^a   Ou, Bor Rung ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

Anti progesterone; bioassay; medicinal plants; progesterone

Indexed keywords

AILANTHUS ALTISSIMA EXTRACT; ANGELICA SINENSIS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; CORTEX EUCOMMIAE EXTRACT; CUSCUTA CHINENSIS EXTRACT; DIOSCOREA OPPOSITA EXTRACT; DIPSACUS ASPEROIDES EXTRACT; EUSCAPHIS JAPONICA EXTRACT; FOLIUM ARTEMISIAE EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HORMONES AND AGENTS ACTING ON THE ENDOCRINE SYSTEM; PERILLA FRUTESCENS EXTRACT; PLANT EXTRACT; PUERARIA MIRIFICA EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; UNCLASSIFIED DRUG; GESTAGEN; HERBACEOUS AGENT; HORMONE ANTAGONIST; MIFEPRISTONE;

BIOASSAY; HERB; MEDICINAL PLANT; MOLECULAR ANALYSIS; TOXIC MATERIAL;

AILANTHUS ALTISSIMA; ANIMAL CELL; ANTIPROGESTOGENIC ACTIVITY; ARTICLE; ATRACTYLODES MACROCEPHALA; BARK; CELL SURVIVAL; CELL VIABILITY; CHINESE HERB; CHINESE MEDICINE; CONTROLLED STUDY; CORTEX EUCOMMIAE; CYTOTOXICITY TEST; DIPSACUS ASPEROIDES; DRUG ACTIVITY; DRUG SCREENING; FOLIUM ARTEMISIAE; HUMAN; HUMAN CELL; MEDICINAL PLANT; NONHUMAN; PLANT LEAF; PLANT ROOT; PLANT STEM; PROGESTOGENIC ACTIVITY; PUERARIA MIRIFICA; CHEMISTRY; ISOLATION AND PURIFICATION; REPORTER GENE; TUMOR CELL LINE;

AILANTHUS ALTISSIMA; ANGELICA SINENSIS; ATRACTYLODES MACROCEPHALA; CUSCUTA CHINENSIS; DIOSCOREA POLYSTACHYA; DIPSACUS ASPEROIDES; EUSCAPHIS JAPONICA; GLYCYRRHIZA URALENSIS; SCUTELLARIA BAICALENSIS;

CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; GENES, REPORTER; HORMONE ANTAGONISTS; HUMANS; MEDICINE, CHINESE TRADITIONAL; MIFEPRISTONE; PLANTS, MEDICINAL; PROGESTINS;

EID: 84904114302     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-014-9434-z     Document Type: Article

References (44)

1. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS and Clarkson TB 1990 Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arterio. Thromb. Vasc. Biol. 10 1051-1057
2. Ahmed HMM, Lin WJ, Yeh JY, Forsberg N, Cheng WTK and Ou BR 2014 Validation of a luciferase bioassay to detect the progestative activity in gilts whose estrus was induced by an uterotonic herb (Ligusticum chuanxiong) . Livest. Sci. doi:10.1016/j.livsci.2014.02.012
3. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW and Toda T 2000 Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 72 844-852 (Pubitemid 30667108)
4. Banno K, Kisu I, Yanokura M, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, et al. 2012 Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review). Int. J. Oncol. 40 1755-1762
5. Beck V, Rohr U and Jungbauer A 2005 Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J. Steroid. Biochemist. Mol. Biol. 94 499-418
6. Cheung AM, Chaudhry R, Kapral M, Jackevicius C and Robinson G 2004 Perimenopausal and postmenopausal health. MBC. Women Health 4 1472-1474
7. Circosta C, Pasquale RD, Palumbo DR, Samperi S and Occhiuto F 2006 Estrogenic activity of standardized extract of Angelica sinensis. Phytotherapy Res. 20 665-669
8. Cogliano V, Grosse Y, Bann R, Straif K, Secretan B and Ghissassi F 2005 Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet. Oncol. 6 552-563
9. Dickerson LM, Pharm D, Mazyck PJ, Pharm D and Hunter MH 2003 Premenstrual Syndrome. Am. Fam. Physician. 67 1743-1752 (Pubitemid 36512816)
10. Freeman EW, Purdy RH, Coutifaris C, Rickels K and Paul SM 1993 Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. J. Neuroendocrinol. 58 478-484 (Pubitemid 23330195)
11. Graham JD and Clarke CL 1997 Physiological action of progesterone in target tissues. Endocrin. Rev. 18 502- 519
12. Hammond R and Johnson J 2004 Endometrial hyperplasia. Curr. Obst. Gynaecol. 40 99-103 (Pubitemid 38327235)
13. Hazra BG and Pore VS 2001 Mifepristone (RU-486), the recently developed antiprogesterone drug and its analogues. J. Indian Inst. Sci. 81 287-298
14. Hillman JJ, Zuckerman IH and Lee E 2004 The impact of the women's health initiative on hormone replacement therapy in a medicaid program. J. Women Health 213 986 - 992
15. Jaakkola S, Lyytinen HK, Dyba T, Ylikorkala O and Pukkala E 2010 Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study. Int. J. Cancer 1 644-651
16. Jung HW, Jung JK, Son KH, Lee DH, Kang TM, Kim YS, Park YK 2012 Inhibitory effects of the root extract of Dipsacus asperoides on collagen-induced arthritis in mice. J. Ethnopharmacol. 139 98-103
17. Kaul A, Nagamani M and Nowicki B 1995 Decreased expression of endometrial decay factor (DAF), a complement regulatory protein, in patients with luteal phase defect. Am. J. Reprod. Immunol. 34 236- 240
18. Klein-Hitpass L, Cato AC, Henderson D and Ryffel GU 1991Two types of anti-progestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucleic Acid Res. 19 1227-1234 (Pubitemid 21913208)
19. Kreikemeier WM and Mader TL 2004 Effects of growth-promoting agents and season on yearling feedlot heifer performance. J. Anim. Sci. 82 2481-2488 (Pubitemid 39103907)
20. Lamberts SW, Koper JW and de Jong FH 1992 Long term treatment with RU486 and glucocorticoid receptor resistance. Theoretical and therapeutic implications. Trends Endocrinol. Metab. 6 199-204
21. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneely OM, et al. 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Gen. Develop. 9 2266-2278
22. Ong VYC and Tan BKH 2007 Novel phytoandrogens and lipidic augmenters from Eucommia ulmoides; BMC Comp. Alter. Med. 7 1- 11
23. Palace VP, Hill MF, Farahmand F and Signal PK 1999 Mobilization of antioxidant vitamin pools and hemodynamic function after myocardial infarction. Circulation 99 121-126 (Pubitemid 29035966)
24. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF and Erdman JW 1998 Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68 1375-1379
25. Rohan TE, Negassa A, Chlebowski RT, Lasser NL, McTiernan A, Schenken RS, Ginsberg M, Wassertheil-Smoller S, et al. 2008 Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol. Bioma. Prev. 17 2337-2343
26. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J. Am. Med. Assoc. 288 321-333 (Pubitemid 34761611)
27. SáFilho OG, Dias CC, Laamb GC and Vasconcelos JL 2010 Pro-gesterone- based estrous synchronization protocols in non-suckled and suckled primiparous Bos indicus beef cows. Anim. Reprod. Sci. 119 9-16
28. Seidlova-Wuttke D, Stecher G, Kammann M, Haunschild J, Eder N, Stahnke V, Wessels J and Wuttke W 2012 Osteoprotective effects of Cimicifuga racemosa and its triterpene-saponins are responsible for reduction of bone marrow fat. Phytomedicine 19 855-860
29. Seifert-Klauss V and Prior JC 2010 Progesterone and bone: actions promoting bone health in women. J. Osteoporos. doi:10.4061/2010/845180
30. Shuai WU, Er-wei LIU, Hong LIU, Meng WANG, Yu HAO and Xiao-yue ZHU 2010 NMR structure elucidation of triterpene saponin isolated from Dipsacus asperoides C.Y. Cheng et T. M. Ai. Chinese J. Magn. Res. 27 661-668
31. Shufelt CL and Merz CNB 2009 Contraceptive hormone use and cardiovascular disease. J. Am. Coll. Cardiol. 53 221-231
32. Spitz IM and Bardin CW 1993 Clinical pharmacology of RU 486- an antiprogestin and antiglucocorticoid. Contraception 48 403-444 (Pubitemid 23357262)
33. Spitz IM 2003 Progesterone antagonists and progesterone receptor modulators: an overview. Steroid. 68 981-993 (Pubitemid 37532423)
34. Stachenfeld NS 2008 Sex hormone effects on body fluid regulation. Exerc. Sport. Sci. Rev. 36 152-159
35. Stanczyk FZ 2003 All progestins are not created equal. Steroid. 68 879-890 (Pubitemid 37532412)
36. Tong IL 2013 Nonpharmacological treatment of postmenopausal symptoms. Obst. Gynaecol. 15 19-25
37. Turgeon JL. McDonnell DP, Martin KA and Wise PM 2004 Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304 269-273
38. Williams JK, Honore EK, Washbum SA and Clarkson TB 1994 Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J. Am. Coll. Cardiol. 24 1757-1761 (Pubitemid 24369203)
39. Winkler UH, Schindler AE, Brinkmann US, Ebrt C and Oberhoff C 2001 Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynecol. Endocrinol. 15 37 - 43
40. Wong RW, Rabie AB and Hagg EU 2007 The effect of crude extract from Radix Dipsaci on bone in micc. Phytotherapy Res. 21 596-598 (Pubitemid 46910242)
41. Yaginuma T, Izumi R, Yasui H, Arai T and Kawabata M 1982 Effect of traditional herbal medicine on serum testosterone levels and its induction of regular ovulation in hyperandrogenic and oligomenorrheic women. Nihon Sanka Fujinka Gakkai Zassahi. 34 939-944 (Pubitemid 12029979)
42. Yang S, Thiel KW, Geest KD and Leslie KK 2011 Endometrial cancer: reviving progesterone therapy in the molecular age. Discov. Med. 12 205-212
43. Yeh JY, Cheng LC, Ou BR, Whanger PD and Chang LW 2002 Differential influences of various arsenic compounds on glutathione redox status and anti-oxidative enzymes in porcine endothelial cells. Cell. Mol. Life Sci. 59 1972-1982 (Pubitemid 36015869)
44. Zhang CZ, Wang SX, Zhang Y, Chen JP and Liang XM 1995 In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. J. Ethnopharmacol. 98 295-300